Paratiroid Karsinomu

Ullah A, Khan J, Waheed A, et al. Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives. Cancers (Basel). 2022;14(6):1426. doi:10.3390/cancers14061426

Talat, N., & Schulte, K. M. (2010). Clinical presentation, staging and long-term evolution of parathyroid cancer. Annals Of Surgical Oncology. 17(8), 2156–2174. https://doi.org/10.1245/s10434-010-1003-6

Taterra D, Wong LM, Vikse J, et al. The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery. Langenbeck's Archives Of Surgery. 2019;404(1):63-70. doi:10.1007/s00423-019-01751-8

Alexander RT, Dimke H. Effects of parathyroid hormone on renal tubular calcium and phosphate handling. Acta physiologica (Oxford, England). 2023;238(1):e13959. doi:10.1111/apha.13959

Ellis H. The story of parathyroid surgery. Journal of Perioperative Practice. 2020;30(7-8):240-241. doi:10.1177/1750458919840997

Goltzman D. Physiology of Parathyroid Hormone. Endocrinology and metabolism clinics of North America. 2018;47 4:743-58. doi:10.1016/j.ecl.2018.07.003

Marcocci C, Cetani F, Rubin M, et al. Parathyroid Carcinoma. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2008;23:1869-80. doi:10.1359/jbmr.081018

Fingeret, Abbey L. “Contemporary Evaluation and Management of Parathyroid Carcinoma.” JCO Oncology Practice vol. 17,1 (2021): 17-21. doi:10.1200/JOP.19.00540

Kong SH, Kim JH, Park MY, et al. Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort. Journal Of Cancer Research And Clinical Oncology. 2021;147(10):3091-3097. doi:10.1007/s00432-021-03576-9

Zelano L, Locantore P, Rota CA, et al. Parathyroid Carcinoma All-In-One, a Rare Life-Threatening Case With Multiple Systemic Manifestations: Case Report and Review of the Literature. Frontiers in Endocrinology (Lausanne). 2022;13:881225. doi:10.3389/fendo.2022.881225

Gill AJ. Understanding the genetic basis of parathyroid carcinoma. Endocrine Pathology. 2014;25(1):30-34. doi:10.1007/s12022-013-9294-3

Zhou R. Parathyroid Carcinoma with Lack of Clinical Symptoms: A Case Report and Review of Literature. Acta Endocrinologica (Bucharest). 2024;20(1):103-6. doi:10.4183/aeb.2024.103

Woodard GE, Lin L, Zhang JH, et al. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene. 2005;24(7):1272-1276. doi:10.1038/sj.onc.1208274

Conti de Freitas LC, Castilho RM, Squarize CH. Histone Modification on Parathyroid Tumors: A Review of Epigenetics. International Journal Of Molecular Sciences. 2022;23(10):5378. doi:10.3390/ijms23105378

Karaarslan S, Yurum FN, Kumbaraci BS, et al. The Role of Parafibromin, Galectin-3, HBME-1, and Ki-67 in the Differential Diagnosis of Parathyroid Tumors. Oman Medical Journal. 2015;30(6):421-427. doi:10.5001/omj.2015.84

Davies MP, John Evans TW, Tahir F, et al. Parathyroid cancer: A systematic review of diagnostic biomarkers. Surgeon. 2021;19(6):e536-e548. doi:10.1016/j.surge.2021.01.011

Salış M, Badak B, Çağa T. Paratiroid Karsinomu: Bir Olgu Sunumu. Osmangazi Tıp Dergisi. 2016;38(3):78-80. doi:10.20515/otd.07990

Givi B, Shah JP. Parathyroid carcinoma. Clinical oncology (Royal College of Radiologists (Great Britain)). 2010;22(6):498-507. doi:10.1016/j.clon.2010.04.007

Elizabeth Shane, Parathyroid Carcinoma, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 2, 1 February 2001, Pages 485–493, doi:10.1210/jcem.86.2.7207

Kowalski GJ, Bednarczyk A, Buła G, et al. Parathyroid carcinoma - a study of 29 cases. Endokrynologia Polska. 2022;73(1):56-63. doi:10.5603/EP.a2022.0003

Rodrigo, J. P., Hernandez-Prera, J. C., Randolph, et al. (2020). Parathyroid cancer: An update. Cancer Treatment Reviews, 86, 102012. https://doi.org/10.1016/j.ctrv.2020.102012

Schulte KM, Talat N. Diagnosis and management of parathyroid cancer. Nature reviews. Endocrinology. 2012;8(10):612-622. doi:10.1038/nrendo.2012.102

Hundahl SA, Fleming ID, Fremgen AM, et al. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86(3):538-544. doi:10.1002/(sici)1097-0142(19990801)86:3<538::aid-cncr25>3.0.co;2-k

Agarwal G, Dhingra S, Mishra SK, et al. Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbeck's Archives of Surgery. 2006;391(6):623-626. doi:10.1007/s00423-006-0095-8

Lo WM, Good ML, Nilubol N, et al. Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma. Annals of Surgical Oncology. 2018;25(9):2535-2540. doi:10.1245/s10434-018-6559-6

Adam, M. A., Untch, B. R., & Olson, J. A., Jr (2010). Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics. Oncologist. 15(1), 61–72. doi:10.1634/theoncologist.2009-0185

Machado NN, Wilhelm SM. Parathyroid Cancer: A Review. Cancers (Basel). 2019;11(11):1676. doi:10.3390/cancers11111676

Lenschow C, Schrägle S, Kircher S, et al. Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma. Annals of Surgery. 2020;275:479-87. doi: 10.1097/SLA.0000000000004144

Kotliarevskaia J, Siebolts U, Dralle H, et al. Late recurrence of a single gland primary hyperparathyroidism-Atypical parathyroid adenoma or misdiagnosed parathyroid carcinoma. Clinical Case Reports. 2024;12(1):e8440. doi:10.1002/ccr3.8440

Okamoto T, Iihara M, Obara T, et al. Parathyroid carcinoma: etiology, diagnosis, and treatment.World Journal of Surgery.2009;33(11):2343-2354. doi:10.1007/s00268-009-9999-0

Tian T, Li X, Zhang J. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy. International Journal of Molecular Sciences. 2019;20(3):755. doi:10.3390/ijms20030755

Kang H, Pettinga D, Schubert AD, et al. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. Oncologist. 2019;24(6):791-797. doi:10.1634/theoncologist.2018-0334